Alzheimer Disease Clinical Trial
Official title:
Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Patients Affected by Alzheimer's Disease and Healthy Controls
High lipid peroxidation and altered antioxidant defenses have been frequently reported in
Alzheimer's disease patients.
The purpose of this study is to investigate susceptibility to photo-oxidation of isolated
erythrocyte membranes, in patients affected by Alzheimer's disease and age- and sex-matched,
non demented subjects.
The study hypothesis is that high lipid peroxidation and decreased antioxidant defenses
characterize the natural history of Alzheimer's disease.
It will be evaluated the release of malondialdehyde (MDA) from ex-vivo photo-oxidized
erythrocyte ghosts, through a very easy and convenient lab procedure for the preparation of
erythrocyte membrane samples.
Isolated and purified red blood cell membranes will be in vitro exposed to oxidative stress
by UV-B radiation. The extent of cell membrane damage will be quantified by the fluorometric
determination of MDA.
Induction of oxidative stress through ultraviolet rays, unlike that obtained by chemical
oxidizing agents, is fully controllable, since it produces effects only during irradiation.
Moreover, using isolated erythrocyte membranes allows for a greater specificity in the
evaluation of MDA produced, and reduces the amount of blood required for the assay.
A portion of the blood sample (500 µL) will be sent to the laboratory of Lipinutragen
(spin-off of CNR- National Research Center Bologna, Italy) where an erythrocyte membrane
lipidomic analysis will be performed for the characterization of membrane phospholipids, in
order to determinate the different lipid components (saturated fatty acids, monounsaturated
and polyunsaturated, trans fatty acids), each one characterized by a different oxidative
reactivity.
Recently published papers showed a striking association between urinary excretion of cortisol
and the increase of some markers of oxidative damage of DNA and RNA (in humans). This finding
provides further support to the idea that chronic psychological stress, who is associated to
hypercortisolemia, can lead to an acceleration of the aging process.
The brain is a major target of the effects of glucocorticoids (CCS). The harmful consequences
of cortisol on the hippocampus (one of the first brain areas affected by Alzheimer's disease)
are well known. Some studies showed inverse correlations between cortisol levels and
neuropsychological performance in patients with depression, dementia as well as in people
treated chronically with CCS.
Alzheimer's disease is associated with states of hypercortisolism. Nonetheless, so far, its
correlation with the level of oxidative stress has not been studied. We will investigate the
relationship between 24h excretion of urinary cortisol and the level of malondialdehyde,
produced by isolated and purified red blood cell membranes, in vitro exposed to oxidative
stress by UV-B radiation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |